This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Inventor Sachin Tanaji Mane: A Pioneer in Racemic Drug Resolution
Introduction
Sachin Tanaji Mane is an innovative inventor based in Pune, India. He has made significant contributions to the field of drug resolution, particularly through his patented process for separating enantiomers. His work is crucial in enhancing the efficacy of pharmaceutical compounds.
Latest Patents
Sachin holds a patent titled "Racemic drug resolution using polymer supported chiral selector." This invention relates to a process for the separation of enantiomers or resolution of racemic mixtures using high surface area core-shell polymer beads. The core-shell functionalized polymer comprises a core made from a copolymer of non-aromatic acrylate, ethylene dimethacrylate, and divinyl-benzene. The shell consists of monomers selected from glycidyl ethers of methacrylate and a chiral selector derived from tartaric acid derivatives and amino acids. He has 1 patent to his name.
Career Highlights
Sachin is affiliated with the Council of Scientific & Industrial Research, where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, particularly in drug formulation and separation techniques.
Collaborations
Some of his notable coworkers include Siona Virgil Daniels and Sarika Babasaheb Deokar. Their collaborative efforts contribute to the ongoing research and development in their respective fields.
Conclusion
Sachin Tanaji Mane is a remarkable inventor whose work in racemic drug resolution showcases his dedication to advancing pharmaceutical sciences. His innovative approach and patented technology have the potential to significantly impact drug development and efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
